TRIPLE-DRUG GVHD PROPHYLAXIS AFTER HLA-MATCHED NON-MYELOABLATIVE ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Wegener, Alma [1 ]
Andersen, Niels Smedegaard [1 ]
Friis, Lone Smidstrup [1 ]
Petersen, Soren Lykke [1 ]
Schjodt, Ida [1 ]
Kornblit, Brian [1 ]
Sengelov, Henrik [1 ]
Gjaerde, Lars Klingen [1 ]
机构：
[1] Rigshospitalet, Copenhagen, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P222
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [41] Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
    Oyama, Y.
    Barr, W. G.
    Statkute, L.
    Corbridge, T.
    Gonda, E. A.
    Jovanovic, B.
    Testori, A.
    Burt, R. K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 549 - 555
  • [42] Non-myeloablative stem cell transplantation in adrenoleukodystrophy
    Kapelushnik, J
    Shapira, Y
    Aker, M
    Hershkoviz, E
    Moser, A
    Selavin, S
    Or, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S51 - S51
  • [43] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    William J. Hogan
    Rainer Storb
    Immunologic Research, 2003, 28 : 1 - 11
  • [44] Non-myeloablative autologous hematopoietic stem cell transplantation for systemic lupus erythematosus
    Statkute, L
    Oyama, Y
    Verda, L
    Barr, WG
    Rosa, R
    Schroeder, J
    Krosnjar, N
    Quigley, K
    Yaung, K
    Villa, M
    Takahashi, MA
    Burt, RK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 9 - 9
  • [45] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    Hogan, WJ
    Storb, R
    IMMUNOLOGIC RESEARCH, 2003, 28 (01) : 1 - 11
  • [46] No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD
    Przybylski, Grzegorz K.
    Kreuzer, Karl-A.
    Siegert, Wolfgang
    Schmidt, Christian A.
    JOURNAL OF APPLIED GENETICS, 2007, 48 (04) : 397 - 404
  • [47] No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD
    Grzegorz K. Przybylski
    Karl-A. Kreuzer
    Wolfgang Siegert
    Christian A. Schmidt
    Journal of Applied Genetics, 2007, 48 : 397 - 404
  • [48] HLA-matched related (MRD) or unrelated donor (URD) non-myeloablative hematopoietic cell transplantation (HCT) for patients (pts) with refractory and relapsed aggressive non Hodgkin lymphoma (NHL).
    Norasetthada, L
    Maris, MB
    Sandmaier, BM
    Gooley, T
    Forman, S
    Agura, E
    Maziarz, RT
    Shizuru, J
    Niederwieser, D
    Storb, R
    Maloney, DG
    BLOOD, 2004, 104 (11) : 634A - 635A
  • [49] Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
    L Johnston
    M Florek
    R Armstrong
    J S McCune
    S Arai
    J Brown
    G Laport
    R Lowsky
    D Miklos
    J Shizuru
    K Sheehan
    P Lavori
    R Negrin
    Bone Marrow Transplantation, 2012, 47 : 581 - 588
  • [50] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O.
    Gutierrez, H.
    Ruiz, G.
    Lopez, A.
    Mancias, C.
    Martinez, S.
    Gonzalez, O.
    Jaime, J.
    Gomez, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 653 - 653
12345